Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.

A J Vincent; M C Esandi; C J Avezaat; C J Vecht; P Sillevis Smitt; D W van Bekkum; D Valerio; P M Hoogerbrugge; A Bout

doi:10.1097/00006123-199708000-00023

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.

Identifier:nobleid.org/w1/20260515/DB0F3D8D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DB0F3D8D.svg?ark=w1%2F20260515%2FDB0F3D8D)](https://nobleid.org/work/w1/20260515/DB0F3D8D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.

Identifier:nobleid.org/w1/20260515/DB0F3D8D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DB0F3D8D.svg?ark=w1%2F20260515%2FDB0F3D8D)](https://nobleid.org/work/w1/20260515/DB0F3D8D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work